Atrial Fibrillation Burden: Impact on Stroke Risk and Beyond

Atrial fibrillation (AF) is an important independent risk factor for stroke. Current guidelines handle AF as a binary entity with risk driven by the presence of clinical risk factors, which guides the decision to treat with an oral anticoagulant. Recent studies in the literature suggest a dose–respo...

Full description

Bibliographic Details
Published in:	Medicina
Main Authors:	Ahmed AlTurki, Vidal Essebag
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Subjects:	atrial fibrillation anticoagulation burden subclinical atrial fibrillation
Online Access:	https://www.mdpi.com/1648-9144/60/4/536

Similar Items

Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
by: Ahmed AlTurki, et al.
Published: (2019-09-01)

Sex-based differences in obstructive sleep apnea and atrial fibrillation: Implication of atrial fibrillation burden
by: Chou-Han Lin, et al.
Published: (2024-02-01)

Use of Oral Anticoagulation in a Real‐World Population With Device Detected Atrial Fibrillation
by: Rachel M. Kaplan, et al.
Published: (2020-12-01)

Meta‐analysis evaluating apixaban in patients with atrial fibrillation and end‐stage renal disease requiring dialysis
by: Ahmed AlTurki, et al.
Published: (2024-06-01)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
by: Celina M. Yong, et al.
Published: (2020-05-01)

Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01)

Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF
by: Linda S. Johnson, et al.
Published: (2024-09-01)

Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
by: Luciana Armaganijan, et al.
Published: (2012-04-01)

The Prevalence of Prescription of New Anticoagulant Drugs and Its Determinant Factors in Patients With Ischemic Stroke and Non-valvular Atrial Fibrillation
by: Yaser Moaddabi, et al.
Published: (2020-03-01)

Evaluation of atrial fibrillation management and cardiovascular risk profile in atrial fibrillation patients: A cross-sectional survey
by: Gediminas Račkauskas, et al.
Published: (2017-01-01)

Rivaroxaban in stroke prevention in patients with non-valvular atrial fibrillation: what facts are important for the clinician?
by: I. S. Yavelov
Published: (2025-08-01)

Metformin reduces new-onset atrial fibrillation risk rather than atrial fibrillation burden in type 2 diabetes patients: A case-control study
by: Chongxia Zhong, et al.
Published: (2024-05-01)

Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation
by: Frederik Dalgaard, et al.
Published: (2020-12-01)

Effects of sufficient anticoagulation on ischemic stroke outcomes in patients with nonvalvular atrial fibrillation
by: Tae Jung Kim, et al.
Published: (2023-12-01)

The Chinese burden of atrial fibrillation review of atrial fibrillation studies in China
by: Jianshu Song
Published: (2022-11-01)

Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines
by: Vrinda Vyas, et al.
Published: (2025-06-01)

A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
by: Andrei Viktorovich Fonyakin, et al.
Published: (2012-09-01)

Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin
by: Jack Ansell
Published: (2017-07-01)

Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
by: E V Schlyakhto, et al.
Published: (2022-01-01)

Do all patients with atrial fibrillation need long-term anticoagulation?
by: Munish Sharma, et al.
Published: (2017-07-01)

THE OPPORTUNITIES FOR RISK REDUCTION OF RECURRENT STROKE IN ATRIAL FIBRILLATION
by: I. L. Davydkin, et al.
Published: (2015-06-01)

Reasons for not prescribing anticoagulants in hospitalized patients with atrial fibrillation and high risk of stroke: what should be the optimal management tactics for these patients?
by: E. I. Baranova, et al.
Published: (2022-07-01)

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation
by: Tomas Forslund, et al.
Published: (2021-08-01)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
by: Jin-Yi Hsu, et al.
Published: (2022-07-01)

Frailty and oral anticoagulant prescription in adults with atrial fibrillation: A systematic review
by: Mary Bul, et al.
Published: (2023-06-01)

Inappropriate dosing of direct oral anticoagulants among very older inpatients with atrial fibrillation
by: Ya-Tong Zhang, et al.
Published: (2025-04-01)

Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
by: Renate B. Schnabel, et al.
Published: (2018-06-01)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
by: Darae Ko, et al.
Published: (2021-11-01)

Association of atrial fibrillation burden and clinical profile with blood biomarkers: Results from the ISOLATION Ablation Cohort
by: Zarina Habibi, MD, et al.
Published: (2025-05-01)

PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01)

Anticoagulation initiation after non ⁃ valvular atrial fibrillation with acute ischemic stroke
by: LU Feng⁃min, et al.
Published: (2024-02-01)

Issues of improving the management of patients with ischemic stroke on the background of atrial fibrillation
by: A. A. Kulesh, et al.
Published: (2022-12-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

Bleeding Risk Scores in Atrial Fibrillation: Helpful or Harmful?
by: Marissa K. Edmiston, et al.
Published: (2018-09-01)

Atrial fibrillation and the brain
by: Dénes Zádori, et al.
Published: (2024-04-01)

EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN
by: I. S. Yavelov
Published: (2016-07-01)

Hemorrhagic Stroke in Atrial Fibrillation: Trends in Incidence, Case Fatality, and Prior Oral Anticoagulation
by: Paula Tiili, et al.
Published: (2025-06-01)

Use of VKAs and NOACs as stroke prophylaxis in patients with atrial fibrillation - a review of the literature
by: Grzegorz Jama, et al.
Published: (2024-08-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants
by: B. Rayner
Published: (2012-10-01)